Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct 27:8:476.
doi: 10.3332/ecancer.2014.476. eCollection 2014.

Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients

Affiliations

Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients

Elzbieta Luczynska et al. Ecancermedicalscience. .

Abstract

Purpose: The aim of this study is to assess the usefulness of perfusion computer tomography (pCT) in prostate cancer (PCa) diagnostics.

Materials and methods: 94 patients with biopsy-proven PCa were enrolled in the study. Dynamic pCT of the prostate gland was performed for 50 seconds after an intravenous injection of contrast medium. Blood flow (BF), blood volume (BV), mean transit time (MTT) and permeability surface area product (PS) were computed in the suspected PCa area and in normal prostatic tissue.

Results: PCa was visible in pCT in 90 of the 94 examined patients as a focal peripheral CT enhancement. When PCa was located in the peripheral zone (PZ), it was visible on perfusion maps, mostly showing an early peak followed by wash-out. The average values of all perfusion parameters were higher for tumour than for normal prostate tissue (p < 0.000). BV and BF were dependent on tumour grade expressed by the Gleason score (GS). All PCa cases were divided into groups, according to histological grade, as low (GS ≤ 6), medium (GS = 7), and high (GS > 7). In high-grade PCa, the mean BF value was significantly higher (p = 0.001) than the mean value of BF low- and medium-grade PCa (p = 0.011). Similar results were obtained regarding the mean values of BV; the more aggressive the cancer grade, the higher the mean BV value (p = 0.04).

Conclusion: CT quantitative perfusion imaging allows PCa to be distinguished from normal prostate tissue. The highest values for BF and BV were observed in the most aggressive PCa grade.

Keywords: angiogenesis; perfusion CT; prostate cancer.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. A time-attenuation curve for PCa and normal tissue. A density–time curve obtained by placing an ROI over the selected arterial input of external iliac artery, neoplastic tissue and healty prostate tissue plotting density (expressed in Hounsfield units (HU)) on the Y-axis and time (expressed in milliseconds) on the X-axis.
Figure 2.
Figure 2.. Region of interest (ROI) in prostate CT perfusion: the manually drawn ROI containing malignant tissue (purple contour on the right side of prostate gland) and healthy tissue (purple contour on the left side of prostate gland).
Figure 3.
Figure 3.. Functional maps of blood flow: (a) blood volume, (b) permeability surface, (c) mean transit time, (d) for PCa and normal tissue. Visualisation of functional maps of PCT parameters, with a focus on regions of interest is presented.
Figure 4.
Figure 4.. Flowchart of patients enrolled in the PCT study. The process of patients’ qualification to the study from included cohort to the final group subjected to analysis. Pts: patients.
Figure 5.
Figure 5.. Differences in perfusion parameters between PCa and normal prostate tissue. The values of CT perfusion parameters. (a) blood volume, (b) blood flow, (c) mean transit time, (d) permeability-surface in malignant and healthy tissue. ■ Mean value, £ Mean ± SE, I Mean ± 1,96*SE.

References

    1. Jemal A, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96. doi: 10.3322/CA.2007.0010. - DOI - PubMed
    1. Mishra MV, et al. Patterns of care for elderly men diagnosed with favorable-risk prostate cancer from 2004 to 2008: a population-based analysis. Am J Clin Oncol. 2013;36(6):606–11. doi: 10.1097/COC.0b013e318261056c. - DOI - PubMed
    1. Kelloff GJ, Choyke P, Coffey DS. Challenges in clinical prostate cancer: role of imaging. Am J Roentgenol. 2009;192(6):1455–70. doi: 10.2214/AJR.09.2579. - DOI - PMC - PubMed
    1. Miller DC, et al. Prostate carcinoma presentation, diagnosis, and staging: an update from the National Cancer Data Base. Cancer. 2003;98(6):1169–78. doi: 10.1002/cncr.11635. - DOI - PubMed
    1. Gupta RT, et al. The state of prostate MRI in 2013. Oncology (Williston Park) 2013;27(4):262–70. - PubMed